Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Shufu Suppository** is a vaginal traditional Chinese medicine suppository developed by Qihuang Pharmaceutical Technology Investment for senile vaginitis with a kidney-deficiency and damp-heat traditional-medicine pattern, corresponding clinically to postmenopausal atrophic vaginitis. A completed, randomized, blinded, parallel-controlled, multicenter Phase 3 study compared Shufu Suppository with Baofukang Suppository and placebo in this population. Its individual herbal constituents and molecular pharmacology were not identified in the available public trial records. ([synapse.zhihuiya.com](https://synapse.zhihuiya.com/drug/13f3d5eb5a8f41e79b94375b296eecf5))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shufu suppository.